Form 8-K - Current report:
SEC Accession No. 0001628908-22-000138
Filing Date
2022-11-02
Accepted
2022-11-02 16:14:07
Documents
15
Period of Report
2022-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 2022.02.11 8-K evh-20221102.htm   iXBRL 8-K 38591
2 EX-99.1 a3q22exhibit991.htm EX-99.1 615348
7 image0a06a.jpg GRAPHIC 110006
  Complete submission text file 0001628908-22-000138.txt   1014471

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evh-20221102.xsd EX-101.SCH 2209
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evh-20221102_def.xml EX-101.DEF 15022
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evh-20221102_lab.xml EX-101.LAB 29172
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evh-20221102_pre.xml EX-101.PRE 15618
9 EXTRACTED XBRL INSTANCE DOCUMENT evh-20221102_htm.xml XML 11345
Mailing Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203
Business Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37415 | Film No.: 221354240
SIC: 8741 Services-Management Services